SWOG clinical trial number
SWOG-9436 (NABTC-9403) (NCI T94-0184)
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma
Closed
Phase
Accrual
95%
Published
Abbreviated Title
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma
Activated
04/18/1995
Closed
02/04/1998
Research committees
Brain Cancer
Publication Information Expand/Collapse
1997
Effects of anticonvulsants (ACs) on the pharmacokinetics (PK) and metabolic profile of paclitaxel.